glp 1 fertility How GLP-1 drug semaglutide may play a role in reproductive health The dual impact of GLP-1

Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence

The JAK-STAT signaling pathway adds another layer

It's the perfect choice for those seeking a healthier option without compromising on taste or energy

According to the platform's website, medication is delivered to your door

Intramuscular injections offer a middle ground